Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.21.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Operating activities    
Net loss $ (47,785) $ (34,398)
Adjustments to reconcile net loss used in operating activities:    
Depreciation and amortization 907 879
Stock-based compensation 4,522 3,902
Accretion of debt discount 104 0
Acquired in-process research and development, including transaction costs 0 25,549
Deferred taxes 31 (424)
Change in fair value of Investment in Aytu 0 (5,208)
Change in fair value of warrant liability and unit purchase option liability 0 (14)
Change in value of Guarantee 0 (1,755)
Changes in assets and liabilities:    
Accounts receivable, net (1,943) (532)
Other receivables 1,210 (1,852)
Inventory, net (17) 9
Prepaid expenses and other assets 910 (24)
Accounts payable (excluding unpaid debt issuance costs) (324) 83
Income taxes payable 0 288
Accrued expenses and other liabilities 4,916 (815)
Lease liability, net (34) 18
Net cash used in operating activities (37,503) (14,294)
Investing activities    
Proceeds from sale of Investment in Aytu, net 0 12,837
Net cash paid in merger with Aevi 0 (1,251)
Purchase of property and equipment (21) 0
Net cash used in investing activities (21) 11,586
Financing activities    
Proceeds from issuance of common stock and pre-funded warrants in underwritten public offering, net 37,653 0
Proceeds from Notes and warrants, net of debt issuance costs paid 19,615 0
Proceeds from underwritten public offering, net 0 35,428
Proceeds from registered direct offering, net 0 5,136
Proceeds from sale of shares pursuant to common stock private placement, net 0 3,888
Proceeds from exercise of stock options 1,568 92
Proceeds from issuance of common stock under employee stock purchase plan 207 133
Restricted stock units withheld for taxes 0 (94)
Net cash provided by financing activities 59,043 44,583
Increase in cash, cash equivalents and restricted cash 21,519 41,875
Cash, cash equivalents, and restricted cash at beginning of period 19,106 3,729
Cash, cash equivalents, and restricted cash at end of period 40,625 45,604
Supplemental disclosures of cash flow information    
Cash paid for taxes 0 316
Supplemental disclosures of non-cash activities    
Unpaid debt issuance costs 1,715 0
Issuance of common stock in Aevi Merger 0 15,496
Leased asset obtained in exchange for new operating lease liability 0 376
Cash and cash equivalents 40,435 45,391
Restricted cash, current 41 33
Restricted cash, non-current 149 180
Total cash, cash equivalents and restricted cash $ 40,625 $ 45,604